Advanced Search
Contact | Corporate | Help

Study of MK-1972 in Human Immunodeficiency Virus (HIV)-1 Infected Participants Who Have Not Previously Received Antiretroviral Therapy (MK-1972-003)

Sponsors:
  • Merck
  • University of Colorado, Denver
  • Duke University
Phases:
  • Phase I
IndicationsAcronym:
  • HIV-1 Infection
Age Groups:
  • Adult
Gender:
Male
Names:
  • Drug: MK-1972
  • Drug: Placebo to MK-1972
Enrollment:
44

Additional information about NCT01353898.


SourceSolution © 2008-2012